Cargando…

Controlling healthcare-associated transmission of SARS-CoV-2 variant of concern 202012/01 in a large hospital network

Detalles Bibliográficos
Autores principales:	Duverger, C., Souyri, V., Monteil, C., Fournier, S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Healthcare Infection Society. Published by Elsevier Ltd. 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8102385/ https://www.ncbi.nlm.nih.gov/pubmed/33965454 http://dx.doi.org/10.1016/j.jhin.2021.04.031

Ejemplares similares

Household clustering of SARS-CoV-2 variant of concern B.1.1.7 (VOC-202012–01) in England
por: Chudasama, Dimple Y., et al.
Publicado: (2021)

SARS-CoV-2 Variant of Concern 202012/01 Has about Twofold Replicative Advantage and Acquires Concerning Mutations
por: Grabowski, Frederic, et al.
Publicado: (2021)

Rapid Spread of the SARS-CoV-2 Variant of Concern 202012/01 in Southern Italy (December 2020–March 2021)
por: Loconsole, Daniela, et al.
Publicado: (2021)

Implications of the Emergence of a New Variant of SARS-CoV-2, VUI-202012/01
por: Rahimi, Farid, et al.
Publicado: (2021)

Dying of VOC-202012/01 — multimodal investigations in a death case of the SARS-CoV-2 variant
por: Heinrich, Fabian, et al.
Publicado: (2021)

New COVID-19 Variant, VUI-202012/01: Molecular Change, Epitope Alteration, and Implication for Vaccine Efficacy
por: Joob, Beuy, et al.
Publicado: (2021)

Decrease of carbapenemase‐producing Enterobacteriaceae incidence during the first year of the COVID‐19 pandemic
por: Duverger, Clarisse, et al.
Publicado: (2022)

Risk of mortality in patients infected with SARS-CoV-2 variant of concern 202012/1: matched cohort study
por: Challen, Robert, et al.
Publicado: (2021)

Near-Complete Genome Sequence of a SARS-CoV-2 VOC 202012/01 Strain in Peru
por: Padilla-Rojas, C., et al.
Publicado: (2021)

Two-step strategy for the identification of SARS-CoV-2 variant of concern 202012/01 and other variants with spike deletion H69–V70, France, August to December 2020
por: Bal, Antonin, et al.
Publicado: (2021)

Discovery of Taroxaz-104: The first potent antidote of SARS-CoV-2 VOC-202012/01 strain
por: Rabie, Amgad M.
Publicado: (2021)

Evaluation of the Diagnostic Value of Hematologic Parameters and Ratios in SARS-CoV-2 VOC-202012/01 Mutant Population
por: Seyit, Murat, et al.
Publicado: (2022)

Investigation of an outbreak of symptomatic SARS-CoV-2 VOC 202012/01-lineage B.1.1.7 infection in healthcare workers, Italy
por: Loconsole, Daniela, et al.
Publicado: (2021)

VOC 202012/01 Variant Is Effectively Neutralized by Antibodies Produced by Patients Infected before Its Diffusion in Italy
por: Rondinone, Valeria, et al.
Publicado: (2021)

Early assessment of diffusion and possible expansion of SARS-CoV-2 Lineage 20I/501Y.V1 (B.1.1.7, variant of concern 202012/01) in France, January to March 2021
por: Gaymard, Alexandre, et al.
Publicado: (2021)

Dieckol and Its Derivatives as Potential Inhibitors of SARS-CoV-2 Spike Protein (UK Strain: VUI 202012/01): A Computational Study
por: Aatif, Mohammad, et al.
Publicado: (2021)

Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial
por: Emary, Katherine R W, et al.
Publicado: (2021)

Estimating COVID-19 cases infected with the variant alpha (VOC 202012/01): an analysis of screening data in Tokyo, January-March 2021
por: Murayama, Hiroaki, et al.
Publicado: (2021)

Performance of the Abbott SARS-CoV-2 IgG II Quantitative Antibody Assay Including the New Variants of Concern, VOC 202012/V1 (United Kingdom) and VOC 202012/V2 (South Africa), and First Steps towards Global Harmonization of COVID-19 Antibody Methods
por: English, Emma, et al.
Publicado: (2021)

Genome Sequence of a SARS-CoV-2 VUI 202012/01 Strain Identified from a Patient Returning from London, England, to the Apulia Region of Italy
por: Loconsole, Daniela, et al.
Publicado: (2021)

Rapid screening for SARS-CoV-2 VOC-Alpha (202012/01, B.1.1.7) using the Allplex™ SARS-CoV-2/FluA/FluB/RSV Assay
por: Giovacchini, Nicla, et al.
Publicado: (2021)

Concerns regarding risk factors for SARS-CoV-2 transmission to pets
por: Weese, Scott
Publicado: (2023)

A comparison of transmissibility of SARS-CoV-2 variants of concern
por: Manathunga, S. S., et al.
Publicado: (2023)

Is diffusion of SARS-CoV-2 variants of concern associated with different symptoms?
por: Mattiuzzi, Camilla, et al.
Publicado: (2022)

The value of electrostatic potentials of the spike receptor binding and N-terminal domains in addressing transmissibility and infectivity of SARS-CoV-2 variants of concern
por: Pascarella, Stefano, et al.
Publicado: (2022)

Salivary IgAs and Their Role in Mucosal Neutralization of SARS-CoV-2 Variants of Concern
por: Diem, Gabriel, et al.
Publicado: (2022)

Rethinking environmental contamination and fomite transmission of SARS-CoV-2 in the healthcare
por: Kanamori, Hajime
Publicado: (2021)

Effect of vaccination on household transmission of SARS-CoV-2 Delta variant of concern
por: Lyngse, Frederik Plesner, et al.
Publicado: (2022)

Ethical Concerns Regarding the Use of Large Language Models in Healthcare
por: Lareyre, Fabien, et al.
Publicado: (2023)

Observations of SARS-CoV-2 variant of concern B.1.1.7 at the UK's largest hospital trust
por: Garvey, Mark I., et al.
Publicado: (2021)

Increased transmissibility and global spread of SARS-CoV-2 variants of concern as at June 2021
por: Campbell, Finlay, et al.
Publicado: (2021)

SARS-CoV-2 N501Y variants of concern and their potential transmission by mouse
por: Huang, Hongyan, et al.
Publicado: (2021)

SARS-CoV-2 Variants of Concern
por: Choi, Jun Yong, et al.
Publicado: (2021)

Idiopathic Intracranial Hypertension Associated with SARS-CoV-2 B.1.1.7 Variant of Concern
por: Khalid, Muhammad Faran, et al.
Publicado: (2021)

Inequalities associated with emergence of Delta SARS-CoV-2 variant of concern (B.1.617.2) in England: awareness for future variants
por: Leeman, D., et al.
Publicado: (2022)

Investigating the possible origin and transmission routes of SARS-CoV-2 genomes and variants of concern in Bangladesh
por: Al Nahid, Abdullah, et al.
Publicado: (2021)

Mutations in SARS-CoV-2 variants of concern link to increased spike cleavage and virus transmission
por: Escalera, Alba, et al.
Publicado: (2022)

Where is the next SARS-CoV-2 variant of concern?
por: Dennehy, John J, et al.
Publicado: (2022)

Substantial immune response in Omicron infected breakthrough and unvaccinated individuals against SARS-CoV-2 variants of concern
por: Yadav, Pragya D., et al.
Publicado: (2022)

A novelly designed protein antagonist confers potent neutralization against SARS-CoV-2 variants of concern
por: Lv, Panjing, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_pqnne8jjj1frocbuiq5fh36ism